Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesSafety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Lakshman M et al. – Testosterone gels are as efficacious as patches and injectable forms in their effects on sexual function and mood. Anticipated increases in prostate–specific antigen with testosterone therapy are not significantly different with testosterone gels, and the risk of polycythemia is ower than injectable modalities. Application site reactions, a major drawback of testosterone patches, occur less frequently with testosterone gels. However, inter–personal transfer is a concern if appropriate precautions are not taken. Superior tolerability and dose flexibility make testosterone gel highly desirable over other modalities of testosterone replacement. Androgel and Testim, the two currently available testosterone gel products in the US, have certain brandspecific properties that clinicians may consider prior to prescribing.
Related Articles
Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09
Relevance Score: 67%
Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09
Relevance Score: 67%
Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09
Relevance Score: 67%
Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09
Relevance Score: 66%
Hypogonadism Risk in Men Treated for Childhood Cancer
Journal of Clinical Endocrinology and Metabolism, 10/12/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
U.S. Opioid Risk Management Initiatives
Pain: Clinical Updates (IASP’s clinical newsletter), 11/20/09
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/20/09
Stress-induced obesity and the emotional nervous system
Trends in Endocrinology and Metabolism, 11/20/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Urinary incontinence and waist circumference in older women
Age and Aging, 11/20/09
Ureter Myogenesis: Putting Teashirt into Context
Journal of the American Society of Nephrology, 11/20/09
Low Annual Caseloads of United States Surgeons Conducting Radical Prostatectomy
The Journal of Urology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor